Search Results - Piotr Serwatowski

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    Ipilimumab in combination with paclitaxel and carboplatin as first-line therapy in extensive-disease-small-cell lung cancer: results from a randomized, double-blind, multicenter phase 2 trial

    Ipilimumab in combination with paclitaxel and carboplatin as first-line therapy in extensive-disease-small-cell lung cancer: results from a randomized, double-blind, multicenter ph... by Martin Reck, Igor Bondarenko, Alexander Luft, Piotr Serwatowski, Fabrice Barlési, Raju Titus Chacko, Martin Sebastian, Huiling Lü, Jean-Marie Cuillerot, Thomas J. Lynch

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Ipilimumab in Combination With Paclitaxel and Carboplatin As First-Line Treatment in Stage IIIB/IV Non–Small-Cell Lung Cancer: Results From a Randomized, Double-Blind, Multicenter Phase II Study

    Ipilimumab in Combination With Paclitaxel and Carboplatin As First-Line Treatment in Stage IIIB/IV Non–Small-Cell Lung Cancer: Results From a Randomized, Double-Blind, Multicenter... by Thomas J. Lynch, Igor Bondarenko, Alexander Luft, Piotr Serwatowski, Fabrice Barlési, Raju Titus Chacko, Martin Sebastian, Joel W. Neal, Haolan Lu, Jean-Marie Cuillerot, Martin Reck

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer

    A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer by C. Manegold, Nico van Zandwijk, A. Szczęsna, Petr Zatloukal, Joseph S. K. Au, Maria Błasińska-Morawiec, Piotr Serwatowski, Maciej Krzakowski, Jacek Jassem, E.H. Tan, Rebecca Benner, Antonella Ingrosso, Sandra J. Meech, David Readett, N. Thatcher

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Phase III Study of Erlotinib in Combination With Cisplatin and Gemcitabine in Advanced Non–Small-Cell Lung Cancer: The Tarceva Lung Cancer Investigation Trial

    Phase III Study of Erlotinib in Combination With Cisplatin and Gemcitabine in Advanced Non–Small-Cell Lung Cancer: The Tarceva Lung Cancer Investigation Trial by U. Gatzemeier, A Płużańska, Aleksandra Szczęsna, E. Kaukel, Jaromı́r Roubec, Flavio De Rosa, Janusz Milanowski, Hanna Karnicka-Mlodkowski, Miloš Pešek, Piotr Serwatowski, Rodryg Ramlau, Terezie Janaskova, Johan Vansteenkiste, János Strausz, Georgy M. Manikhas, Joachim von Pawel

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Phase III Study of Pemetrexed Plus Carboplatin Compared With Etoposide Plus Carboplatin in Chemotherapy-Naive Patients With Extensive-Stage Small-Cell Lung Cancer

    Phase III Study of Pemetrexed Plus Carboplatin Compared With Etoposide Plus Carboplatin in Chemotherapy-Naive Patients With Extensive-Stage Small-Cell Lung Cancer by Mark A. Socinski, Egbert F. Smit, Paul Lorigan, Kartik Konduri, Martin Reck, Aleksandra Szczęsna, Johnetta Blakely, Piotr Serwatowski, Nina Karaseva, Tudor‐Eliade Ciuleanu, Jacek Jassem, Mircea Dediu, Shengyan Hong, Carla Visseren‐Grul, Axel-Rainer Hanauske, Coleman K. Obasaju, Susan C. Guba, Nick Thatcher

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Adjuvant Erlotinib Versus Placebo in Patients With Stage IB-IIIA Non–Small-Cell Lung Cancer (RADIANT): A Randomized, Double-Blind, Phase III Trial

    Adjuvant Erlotinib Versus Placebo in Patients With Stage IB-IIIA Non–Small-Cell Lung Cancer (RADIANT): A Randomized, Double-Blind, Phase III Trial by Karen Kelly, Nasser K. Altorki, Wilfried Eberhardt, Mary O’Brien, David R. Spigel, Lucio Crinò, Chun-Ming Tsai, Joo-Hang Kim, Eun Kyung Cho, Philip C. Hoffman, С. В. Орлов, Piotr Serwatowski, Jiuzhou Wang, Margaret A. Foley, Julie D. Horan, Frances A. Shepherd

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer

    Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer by Giorgio V. Scagliotti, Purvish Parikh, Joachim von Pawel, Bonne Biesma, Johan Vansteenkiste, Christian Manegold, Piotr Serwatowski, U. Gatzemeier, Raghunadharao Digumarti, Mauro Zukin, Jin S. Lee, Anders Mellemgaard, Keunchil Park, Shehkar Patil, Janusz Rolski, Tuncay Göksel, Filippo de Marinis, Lorinda Simms, Katherine P. Sugarman, David R. Gandara

    Published 2008
    Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Anetumab ravtansine versus vinorelbine in patients with relapsed, mesothelin-positive malignant pleural mesothelioma (ARCS-M): a randomised, open-label phase 2 trial

    Anetumab ravtansine versus vinorelbine in patients with relapsed, mesothelin-positive malignant pleural mesothelioma (ARCS-M): a randomised, open-label phase 2 trial by Hedy L. Kindler, Silvia Novello, Alessandra Bearz, Giovanni Luca Ceresoli, Joachim G.J.V. Aerts, James Spicer, Paul Taylor, Kristiaan Nackaerts, Alastair Greystoke, Ross Jennens, Luana Calabrò, Jacobus A. Burgers, Armando Santoro, S. Cedrés, Piotr Serwatowski, Santiago Ponce, Jan P. van Meerbeeck, Anna K. Nowak, George R. Blumenschein, Jonathan Siegel, Linda Kasten, Karl Köchert, Annette O. Walter, Barrett H. Childs, Cem Elbi, Raffit Hassan, Dean A. Fennell

    Published 2022
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: